250 related articles for article (PubMed ID: 21128871)
21. Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma.
Babidge WJ; Butler LM; Burton MA; Cowled PA
Anticancer Res; 2001; 21(4A):2809-14. PubMed ID: 11724359
[TBL] [Abstract][Full Text] [Related]
22. Allele and genotype frequencies of the polymorphic methylenetetrahydrofolate reductase and colorectal cancer among Jordanian population.
Yousef AM; Shomaf M; Berger S; Ababneh N; Bobali Y; Ali D; Al-Hasan S; Diab O; Ismail S
Asian Pac J Cancer Prev; 2013; 14(8):4559-65. PubMed ID: 24083702
[TBL] [Abstract][Full Text] [Related]
23. [Association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and the risk of sporadic colorectal cancer].
Baghad I; Erreguibi D; Boufettal R; Eljai SR; Chihab F; Nadifi S
Pan Afr Med J; 2021; 38():287. PubMed ID: 34122714
[TBL] [Abstract][Full Text] [Related]
24. Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status.
Mokarram P; Naghibalhossaini F; Saberi Firoozi M; Hosseini SV; Izadpanah A; Salahi H; Malek-Hosseini SA; Talei A; Mojallal M
World J Gastroenterol; 2008 Jun; 14(23):3662-71. PubMed ID: 18595133
[TBL] [Abstract][Full Text] [Related]
25. A study of the MTHFR gene polymorphism C677T in colorectal cancer.
Derwinger K; Wettergren Y; Odin E; Carlsson G; Gustavsson B
Clin Colorectal Cancer; 2009 Jan; 8(1):43-8. PubMed ID: 19203896
[TBL] [Abstract][Full Text] [Related]
26. MTHFR C677T polymorphism and anatomopathological characteristics with prognostic significance in sporadic colorectal cancer.
Delgado-Plasencia L; Álvarez-Argüelles H; Salido-Ruiz E; Castro-Peraza ME; Bravo-Gutiérrez A; Fernández-Peralta A; González-Aguilera J; Alarcó-Hernández A; Medina-Arana V
Pathol Res Pract; 2015 Dec; 211(12):989-95. PubMed ID: 26564107
[TBL] [Abstract][Full Text] [Related]
27. Association of Methylenetetrahydrofolate Reductase rs1801133 Gene Polymorphism with Cancer Risk and Septin 9 Methylation in Patients with Colorectal Cancer.
Huang Y; Su T; Duan Q; Wei X; Fan X; Wan J; Liu L; Dian Z; Zhang G; Sun Y; Zhou T; Xu Y
J Gastrointest Cancer; 2024 Jun; 55(2):778-786. PubMed ID: 38252186
[TBL] [Abstract][Full Text] [Related]
28. [C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population].
Zúñiga-Noriega JR; Velazco-Campos Mdel R; Aguirre-Rodríguez A; Villarreal LM; Garza-González E; Maldonado-Garza HJ; Bosques-Padilla FJ
Rev Gastroenterol Mex; 2007; 72(4):355-8. PubMed ID: 18595323
[TBL] [Abstract][Full Text] [Related]
29. Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity.
Chen D; Song S; Lu J; Luo Y; Yang Z; Huang Q; Fu X; Fan X; Wei Y; Wang J; Wang L
Carcinogenesis; 2011 Jul; 32(7):1043-9. PubMed ID: 21393476
[TBL] [Abstract][Full Text] [Related]
30. C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas.
Kafadar AM; Yilmaz H; Kafadar D; Ergen A; Zeybek U; Bozkurt N; Kuday C; Isbir T
Anticancer Res; 2006; 26(3B):2445-9. PubMed ID: 16821630
[TBL] [Abstract][Full Text] [Related]
31. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?
Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):659-68. PubMed ID: 10744125
[TBL] [Abstract][Full Text] [Related]
32. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
33. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
34. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
35. Association of the 677C -->T polymorphism in the MTHFR gene with colorectal cancer in Mexican patients.
Gallegos-Arreola MP; García-Ortiz JE; Figuera LE; Puebla-Pérez AM; Morgan-Villela G; Zúñiga-González GM
Cancer Genomics Proteomics; 2009; 6(3):183-8. PubMed ID: 19487547
[TBL] [Abstract][Full Text] [Related]
36. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
Martínez ME; Thompson P; Jacobs ET; Giovannucci E; Jiang R; Klimecki W; Alberts DS
Gastroenterology; 2006 Dec; 131(6):1706-16. PubMed ID: 17087956
[TBL] [Abstract][Full Text] [Related]
37. One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study.
Van Guelpen B; Dahlin AM; Hultdin J; Eklöf V; Johansson I; Henriksson ML; Cullman I; Hallmans G; Palmqvist R
Cancer Causes Control; 2010 Apr; 21(4):557-66. PubMed ID: 20012180
[TBL] [Abstract][Full Text] [Related]
38. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic.
Pardini B; Kumar R; Naccarati A; Prasad RB; Forsti A; Polakova V; Vodickova L; Novotny J; Hemminki K; Vodicka P
Mutat Res; 2011 Mar; 721(1):74-80. PubMed ID: 21211571
[TBL] [Abstract][Full Text] [Related]
39. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
[TBL] [Abstract][Full Text] [Related]
40. Promoter Hypermethylation of Wnt/β-catenin Signaling Pathway Inhibitor
Jalilvand A; Soltanpour MS
Oman Med J; 2020 May; 35(3):e131. PubMed ID: 32607254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
